PharmaNutra SpA (IT:PHN) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
PharmaNutra S.p.A. has signed a distribution agreement with Sigma Lifesciences to market its SiderAL® and Ultramag® products in Canada, expanding its presence in North America. The products, which feature the patented Sucrosomial® Technology, are set to launch in the second quarter of 2025. This strategic move aims to capitalize on the significant market potential in Canada.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.